Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCirata Regulatory News (CRTA)

Share Price Information for Cirata (CRTA)

Share Price is delayed by 15 minutes
Get Live Data
17.00    0.00 (0.00%)
Bid:
16.55
Ask:
17.00
Spread: 0.45 (2.719%)
Market Cap: £21.50m
CRTA Live PriceLast checked at - London Stock Exchange

Intraday Cirata Share Chart

Management Changes

31 Mar 2026 15:39

RNS Number : 9060Y
Cirata PLC
31 March 2026
 

31 March 2026

 

 

Cirata plc

("Cirata" or the "Company")

 

Management Changes

 

Cirata (LSE: CRTA), announces that following the completion of the audit for the year ended 31 December 2025, Ricardo Moura CFO who joined Cirata 30 September 2024 on a fixed term contract will be leaving Cirata 31 May 2026. Ed Kee, who joined Cirata in December 2024 in Belfast and currently serves as the Group's financial controller, has been appointed as Finance Director with immediate effect and will work with Ricardo during the handover period to ensure a smooth transition.

 

Ed qualified as a Chartered Accountant at Ernst & Young and has over 10 years' experience working as a financial controller. Ed with Ricardo, helped lead the relocation of our finance operations to Belfast, and his immediate appointment ensures total continuity.

 

The company acknowledges the work undertaken by Ricardo on the Company's restructuring, its divestment of Dev Ops and the transition of the Finance team from Newcastle to Belfast and wishes him well for the future.

 

 

Stephen Kelly, Chief Executive Officer, commented:

 

"I am delighted to appoint Ed Kee as Finance Director. Since joining us in Belfast, Ed has been instrumental in the seamless transition of our finance function and has demonstrated the financial oversight required for our next phase of growth. With the Dev Ops divestment and our core restructuring now complete, Ed is well placed to help lead our finances as we focus on the scaling of our Data Integration business. We thank Ricardo for his contribution during a pivotal time for Cirata and wish him well in his next step."

 

 

For further information, please contact: 

Cirata

+1 (925) 380 1728

Stephen Kelly, Chief Executive Officer

Ricardo Moura, Chief Financial Officer

Daniel Hayes, Investor Relations

FTI Consulting

+44 (0)20 3727 1137

Matt Dixon / Kwaku Aning / Usama Ali

Stifel (Nomad and Joint Broker)

+44 (0)20 7710 7600

Fred Walsh / Brough Ransom / Ben Good / Dan Dearden-Williams

Panmure Liberum (Joint Broker)

+44 (0)20 3100 2000

James Sinclair-Ford / Rupert Dearden / John More

 

About Cirata 

Cirata, accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated.

 

For more information about Cirata, visit www.cirata.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEALDFDDXKEFA
Date   Source Headline
30th Sep 20247:00 amRNSHCSC Contract Renewal
25th Sep 20247:00 amRNSAppointment of Interim CFO
19th Sep 202410:30 amRNSHolding(s) in Company
19th Sep 202410:30 amRNSHolding(s) in Company
4th Sep 20247:00 amRNSInterim results
31st Jul 20245:44 pmRNSHolding(s) in Company
31st Jul 20242:35 pmRNSDirector/PDMR Shareholding
26th Jul 20241:51 pmRNSHolding(s) in Company
19th Jul 20245:54 pmRNSDelay of Admission
17th Jul 20247:00 amRNSResult of Fundraising
16th Jul 20244:47 pmRNSPrimaryBid Offer
16th Jul 20244:46 pmRNSLaunch of Fundraise
16th Jul 20244:45 pmRNSQ2 Trading Update and Outlook
28th Jun 20248:00 amRNSBlock Listing Return
25th Jun 20247:08 amRNSGM Launches Phase 2
19th Jun 20247:00 amRNSTotal Voting Rights
21st May 20247:00 amRNSOPPO Contract Renewal
14th May 20243:28 pmRNSResult of Annual General Meeting
29th Apr 20245:01 pmRNSFurther re: Annual Report & Notice of AGM
24th Apr 20247:00 amRNSDirectorate Change
17th Apr 20243:05 pmRNSAnnual Report & Notice of AGM
9th Apr 20247:00 amRNSQ1 FY24 Trading Update
4th Apr 20247:00 amRNSFinal Results
6th Mar 20245:19 pmRNSHolding(s) in Company
4th Mar 20242:53 pmRNSHolding(s) in Company
21st Feb 20241:27 pmRNSHolding(s) in Company
15th Feb 20244:27 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSChair appointment
9th Jan 20247:00 amRNSTrading Update
4th Jan 20243:10 pmRNSTotal Voting Rights
4th Jan 20242:41 pmRNSHolding(s) in Company
3rd Jan 20245:40 pmRNSHolding(s) in Company
2nd Jan 20249:32 amRNSNotice of Q4 FY23 Trading Update
14th Dec 20236:12 pmRNSBlock Listing Application
12th Dec 20235:32 pmRNSGrant of Share Options to PDMRs
12th Dec 20238:29 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSTotal Voting Rights
5th Dec 202310:25 amRNSHolding(s) in Company
24th Nov 20235:40 pmRNSDirector/PDMR Shareholding
23rd Nov 202310:08 amRNSHolding(s) in Company
21st Nov 20235:41 pmRNSHolding(s) in Company
21st Nov 20231:28 pmRNSHolding(s) in Company
21st Nov 20237:00 amRNSDirector/PDMR Shareholding
17th Nov 20235:54 pmRNSDirector/PDMR Shareholding
8th Nov 20231:18 pmRNSHolding(s) in Company
7th Nov 20232:39 pmRNSTotal Voting Rights
2nd Nov 20237:00 amRNSChange of Auditor
27th Oct 20235:12 pmRNSHolding(s) in Company
18th Oct 20237:00 amRNSTrading Update and Outlook

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.